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Abstract
A GGG GCC hexanucleotide repeat expansion in the C9orf72 gene is the most common genetic cause of amyotrophic lateral 
sclerosis and frontotemporal dementia. Neurodegeneration may occur via transcription of the repeats into inherently toxic 
repetitive sense and antisense RNA species, or via repeat-associated non-ATG initiated translation (RANT) of sense and 
antisense RNA into toxic dipeptide repeat proteins. We have previously demonstrated that regular interspersion of repeat 
RNA with stop codons prevents RANT (RNA-only models), allowing us to study the role of repeat RNA in isolation. Here we 
have created novel RNA-only Drosophila models, including the first models of antisense repeat toxicity, and flies expressing 
extremely large repeats, within the range observed in patients. We generated flies expressing ~ 100 repeat sense or anti-
sense RNA either as part of a processed polyadenylated transcript or intronic sequence. We additionally created Drosophila 
expressing > 1000 RNA-only repeats in the sense direction. When expressed in adult Drosophila neurons polyadenylated 
repeat RNA is largely cytoplasmic in localisation, whilst intronic repeat RNA forms intranuclear RNA foci, as does > 1000 
repeat RNA, thus allowing us to investigate both nuclear and cytoplasmic RNA toxicity. We confirmed that these RNA foci 
are capable of sequestering endogenous Drosophila RNA-binding proteins, and that the production of dipeptide proteins 
(poly-glycine–proline, and poly-glycine–arginine) is suppressed in our models. We find that neither cytoplasmic nor nuclear 
sense or antisense RNA are toxic when expressed in adult Drosophila neurons, suggesting they have a limited role in disease 
pathogenesis.
Keywords C9orf72 · Drosophila · ALS · FTD · Repeat expansion
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Introduction
Amyotrophic lateral sclerosis (ALS) and frontotemporal 
dementia (FTD) are two adult onset, neurodegenerative 
diseases, leading to loss of the upper and lower motor neu-
rons, or frontal and temporal lobe cortical neurons, respec-
tively. In recent years, it has become apparent that these 
diseases represent extremes of a clinical and pathologi-
cal spectrum of disorders, since genetic evidence shows 
that either or both of these clinical manifestations can be 
caused by mutations in the same set of genes [33].
A (GGG GCC )n hexanucleotide expansion within the 
first intron of the C9orf72 gene is the most common 
genetic cause of both ALS and FTD, causing up to 40% 
of familial ALS and 25% of familial FTD [16, 35, 45]. 
Unaffected individuals typically carry 2–10 repeats, whilst 
patients harbour hundreds to thousands [16, 45]. Toxicity 
has been proposed to result either from a loss of func-
tion of the C9orf72 gene, or a toxic gain of function [46]. 
Neuron-specific, or whole genome knockout of the mouse 
ortholog of C9orf72 does not lead to a neurodegenera-
tive phenotype, suggesting that toxicity primarily arises 
through a gain of function mechanism [3, 8, 26, 29, 31, 
51, 52]. Two such mechanisms have been proposed: RNA 
toxicity, or toxicity arising due to proteins derived from 
the repeat RNA [39].
The hexanucleotide repeat can be transcribed in both 
sense and antisense directions, resulting in sense and anti-
sense RNA foci, typically nuclear aggregates of RNA. 
These have been proposed to exert toxicity by sequestering 
RNA-binding proteins [16, 20, 38, 45, 59]. Additionally, 
sense and antisense RNA can be translated in all reading 
frames, via repeat-associated non-ATG initiated transla-
tion (RANT), producing five dipeptide proteins (DPRs): 
poly-GR, poly-GA, and poly-GP from the sense stand, and 
poly-PR, poly-AP, and poly-GP from the antisense [2, 40, 
59].
We and others have previously demonstrated that 
expression of hexanucleotide RNA is extremely toxic to 
adult Drosophila neurons, resulting in dramatically short-
ened lifespan [19, 37, 56]. However, insertion of regularly 
interspersed stop codons (“RNA-only” constructs) within 
the hexanucleotide sequence rescues toxicity, suggest-
ing that it is primarily mediated by DPRs [37]. Multiple 
groups have demonstrated that among the DPRs, poly-GR, 
and poly-PR are the most toxic, with poly-GA exerting 
toxicity in some model systems [39].
Despite these advances, the potential role of RNA toxic-
ity in C9orf72 mutation-associated ALS/FTD is not fully 
resolved. Recent work has suggested that expression of 
sense RNA is toxic to rat primary neurons [54] and that 
cytoplasmic rather than nuclear RNA may drive pathol-
ogy [9]. The role of antisense RNA in isolation has not 
yet been assessed.
RNA-only constructs provide the ideal tool to assess 
a role of C9orf72 repeat RNA without the confounding 
effect of RANT DPRs. Here we examine whether genomic 
context or repeat length can cause RNA-only (RO) repeats 
to be toxic to Drosophila neurons. We find that expressing 
RO repeats as part of an intron potentiates sense and anti-
sense intranuclear RNA foci formation, as does express-
ing extremely long repeats within the range observed in 
patients (> 1000 repeats). However, we find no evidence 
of toxicity arising due to sense or antisense repeat RNA, 
despite observing sequestration of RNA-binding proteins 
by RNA foci.
Materials and methods
Generation of DNA constructs
Recursive directional ligation was used to generate 
108RO and ~ 1152RO constructs in the pBluescript vec-
tor as previously described [37]. The repeat sequence was 
subsequently subcloned into the pUAST attB Drosophila 
transgenesis vector to generate sense polyA constructs. 
For antisense polyA constructs, the 108RO sequence was 
cloned in reverse. For the sense intronic construct: the 
pUAST attB vector was modified to remove XbaI and 
BamHI restriction sites. The pGint vector [7] (Addgene 
Plasmid #24217) was digested with BglII and NotI to lib-
erate the eGFP coding sequence, and this was subcloned 
into a modified pUAST attB vector (pUAST attB eGFP). 
Following this, repeats were subcloned from the sense-
polyA vector into the intronic region using the BamHI and 
XbaI restriction sites within the eGFP intronic sequence. 
To generate antisense intronic constructs: the origin of 
replication of the pUAST attB eGFP vector was reversed, 
the original EcoRI site was removed from upstream of 
the eGFP sequence, and an EcoRI cut site was introduced 
into the intronic region of the eGFP sequence, the repeats 
were cloned in antisense orientation from the sense-polyA 
vector using EcoRI and XbaI.
Plasmids were propagated and purified in the man-
ner described previously [37]. Repeat size was con-
firmed using DNA digestion (~ 1152RO construct) and/
or sequencing with dGTP (Source Bioscience). Due to 
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minor repeat contraction events, the final repeat numbers 
in each plasmid are: 108 repeats (sense polyA and anti-
sense intronic constructs), 107 repeats (antisense polyA 
construct) and 106 (sense intronic construct). Sequences 
are available on request.
Generation of transgenic Drosophila
Constructs were inserted using phiC31-integrase-mediated, 
site-directed insertion at the attP40 locus [36]. Constructs 
were injected into y1, M{vas-int.B}ZH-2A w*; P{CaryP}
attP40 embryos and the phiC31 integrase was removed by 
crossing transgenic males to females for two successive gen-
erations before use in phenotyping experiments.
Drosophila stocks and maintenance
Drosophila stocks were maintained on SYA food (15 g/L 
agar, 50 g/L sugar, 100 g/L autolysed yeast, 30 mL/L nipagin 
(10% in ethanol) and 3 mL/L propionic acid) at 25 °C in a 
12-h light–dark cycle with constant humidity. For RU486-
induced experiments, food was supplemented with 200 μM 
RU486 (mifepristone).
The elavGS stock was generously provided by Herve 
Tricoire (Paris Diderot University) [43]. The GMR-Gal4 
line was obtained from the Bloomington Drosophila Stock 
Centre. The Glorund RNAi line was obtained from the 
Vienna Drosophila Resource Center (GD12082, v27752). 
All experiments were performed on mated females, unless 
otherwise stated.
Lifespan assays
Flies were raised at standard density in 200-mL bottles. 
After eclosion, flies were allowed to mate for 48 h. 135–150 
flies of the indicated genotype were split into groups of 15 
and housed in vials containing SYA medium with or with-
out RU486. Deaths were scored, and flies tipped onto fresh 
food three times a week. Data are presented as cumulative 
survival curves. All lifespans were performed at 25 °C.
Negative geotaxis assays
Negative geotaxis assays were performed as described pre-
viously, either using technical replicates of ~ 75 flies in a 
glass-walled chamber [41], or 3 replicates of 15 flies in plas-
tic pipettes [49] (Fig. 2). Performance indexes were calcu-
lated as described previously [49].
Fluorescence in situ hybridization (FISH)
Adult females of the indicated genotype were allowed to 
feed on RU486 containing food for 7 days. Brains were 
dissected and FISH performed as described elsewhere [53]. 
The following probes were used: Cy3-labelled (GGC CCC 
)4 2′-O-methyl RNA probe (Integrated DNA Technologies) 
[38], and 5′ TYE563-labelled (GGG GCC )3 probe (Exiqon). 
Following the FISH protocol, brains were mounted in 
Vectashield mounting medium with DAPI (Vectorlabs). 
Images were taken using a Zeiss LSM 700 confocal micro-
scope, using the 63× lens and the same settings within each 
experiment. For foci quantification, images were taken with-
out prior visualization of the Cy3 channel to avoid experi-
menter induced bias. Numbers of nuclei and foci containing 
nuclei were scored with experimenter blinded to genotype.
FISH immunofluorescence
Following the FISH protocol, brains were blocked for 1 h 
in blocking solution [PBS with 0.3% Triton X-100 and 10% 
BSA (Sigma)], before being incubated overnight at 4°C with 
anti-Glorund primary antibody (5B7, Developmental Stud-
ies Hybridoma Bank) at a concentration of 1/100 in block-
ing solution. The following day the tissue was washed three 
times in PBST before being incubated in Alexa-488-conju-
gated goat anti-mouse secondary antibody (A11001, Thermo 
Fisher) at 1/1000 in block at room temperature for 1 h. Fol-
lowing three further washes, the brains were mounted as 
described above. Images were taken using a Zeiss LSM 700 
confocal microscope, using the same settings. Foci overlap 
with Glorund puncta was quantified automatically using 
Volocity analysis software (Perkin Elmer).
Dipeptide immunoassays
Antibodies were produced by immunising rabbits with 
either (GP)7, or (GR)7 followed by affinity purification and 
a proportion biotinylated (Eurogentec) [48]. Adult flies of 
the indicated genotypes were fed food containing 200 µM 
RU486 or control food for 7 days. Flies were frozen in liquid 
nitrogen and heads removed. 7–10 heads per replicate were 
homogenised in ice-cold RIPA buffer (Sigma) with protease 
inhibitors (Roche cOmplete mini EDTA-free). Lysis was 
allowed to proceed on ice for 10 min, before lysates were 
centrifuged at 21,000×g for 20 min at 4 °C. Supernatant 
was collected in fresh tubes. The concentration of protein 
was determined using the DC protein assay (BioRad). Con-
centration of lysates were made equivalent by the addition 
of further RIPA buffer with protease inhibitors. The total 
amount of protein loaded per well in each assay was 24 μg 
for poly-GR and 14 μg for poly-GP.
Immunoassays were performed using 96-well SECTOR 
plates (MSD, Rockville, Maryland) as described previously 
[48, 50]. Detection was performed using an MSD sector 
imager. Specificity was confirmed with a peptide cross 
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reactivity assay using (GP)7, (GR)7, (GA)7, (PR)7, and (AP)7 
synthetic peptides (Biogenes) at a concentration of 100 ng/
mL. For Drosophila assays lysates from wild-type flies 
(w1118) were run on each plate, and the resultant values 
subtracted from all samples to correct for background. A 
four-parameter logistic regression curve was fit to the values 
obtained from a standard curve of peptide calibrators using 
graph pad prism, and concentrations were interpolated.
Statistics
Lifespan data were compared using log rank test. For nega-
tive geotaxis analysis, counts of flies at each height were 
compared using ordinal logistic regression. For percentage 
foci positive nuclei data, a linear model with genotype as 
the explanatory variable was fitted. Comparisons were made 
using a priori orthogonal contrasts.
Results
Generation of transgenic Drosophila expressing 
sense RNA‑only repeats either within an intron 
or as a polyadenylated transcript
We have previously created Drosophila capable of induc-
ible expression of 108 sense RO repeats as part of a capped 
and polyadenylated (polyA) transcript [37]. However, the 
genomic location of the repeat region in humans is either 
within the first intron of the C9orf72 gene or within the pro-
moter, depending on the splice variant [16, 45]. We, there-
fore, created a Drosophila model capable of expressing 106 
RO hexanucleotide repeats from within a strongly, consti-
tutively, spliced artificial intron introduced into an eGFP 
coding sequence (Fig. 1a) [7]. Constructs were integrated 
at the same genomic site to ensure equivalent expression 
levels. Because plasmids containing repetitive DNA ele-
ments are unstable in bacteria, and repeat length tracts can 
be unstable in Drosophila [28], we derived multiple inde-
pendent transgenic lines and screened for repeat expansions 
of the correct size using Southern blotting (Online Resource 
Fig. 1) and selected two lines capable of expressing ~ 100 
RO sense repeats either as part of a processed RNA tran-
script (Sense-PolyA-1 and Sense-PolyA-2) or from an intron 
(Sense-Intronic-1 and Sense-Intronic-2). We additionally 
confirmed expression of eGFP in intronic flies, indicating 
that the intronic repeat region is efficiently spliced out of the 
mature mRNA transcript (Online Resource Fig. 2).
Sense polyA repeat RNA accumulates 
in the cytoplasm and intronic repeat RNA 
accumulates in the nucleus
To test whether the genomic context of the repeat alters 
the formation of RNA foci in our models we performed 
RNA fluorescent in  situ hybridisation (FISH) in adult 
Drosophila neurons. Sense polyA or sense intronic RO 
repeats were expressed in adult neurons using the pan-
neuronal, inducible, Elav gene-switch (elavGS) driver, 
with expression induced after eclosion. In both types of 
fly, foci were observed in adult neurons (Fig. 1b) and not 
in driver-only controls (Fig. 2b, Online Resource Fig. 3). 
In sense polyA RO repeat-expressing flies, we observed a 
primarily cytoplasmic RNA signal in adult neurons, with 
occasional (5–6% of cells) intranuclear puncta (Figs. 1b, 
2b). However, in sense intronic RO repeat-expressing flies 
we observed a shift in RNA localisation to predominantly 
nuclear RNA foci, present in 11–22% of neurons (Fig. 2b). 
The differential localisation of RNA in these lines allows 
investigation of both cytoplasmic and nuclear C9orf72 
repeat RNA toxicity.
Sense cytoplasmic RNA and nuclear RNA foci 
do not cause typical neurodegenerative phenotypes
To determine whether C9orf72 sense RNA can lead to neu-
rodegenerative phenotypes, we assessed the effect of adult 
pan-neuronal expression of sense polyA and sense intronic 
RO repeats on the survival of Drosophila. We observed 
that expression of sense polyA or sense intronic repeats 
did not reduce adult survival compared to controls where 
no expression was induced; in fact, a significant exten-
sion of lifespan was observed (Fig. 1c, Online Resource 
Fig. 4a, c). This lifespan extension did not occur in flies 
carrying the driver alone, or expressing a non-toxic DPR 
protein inserted in the same locus (Online resource Fig. 5). 
As an alternative metric of neuronal health, we assessed 
the climbing ability of adult flies using negative geotaxis 
assays. For sense polyA expressing flies, we observed a 
slight reduction in climbing ability with age across both 
replicates compared to controls, but saw no consistent 
reduction in climbing ability with age in sense intronic RO 
repeat-expressing flies (Fig. 1d, Online Resource Fig. 6a, 
c). We have previously shown that expression of pure (non 
RNA-only) repeats during development at high tempera-
tures, a mildly stressful condition, led to a very strong 
eye phenotype [37]. To analyse whether the RO repeats 
would also show a phenotype under these conditions we 
expressed the constructs in the developing Drosophila 
compound eye using the GMR-Gal4 driver, assessing both 
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roughness of the adult eye and the percentage of pupae that 
eclosed (Online Resource Fig. 7). No RO lines, polyA or 
intronic, showed an eclosion defect. A slight rough eye 
phenotype was observed in female (but not male) flies 
expressing polyA repeats, potentially due to the produc-
tion of small amount of DPRs in these flies (see “Discus-
sion”). Intronic repeat expressing flies did not demonstrate 
a rough eye phenotype or eclosion defect, consistent with 
a lack of toxicity of nuclear RNA foci.
Expression of > 1000 sense RNA‑only repeats 
generates many RNA foci
C9orf72 ALS/FTD patients typically carry thousands of 
repeats [4, 5]. We, therefore, consider that we might not 
yet have achieved a repeat length sufficient to induce RNA 
toxicity. To test this hypothesis, we generated Drosoph-
ila capable of expressing ~ 1000 RNA-only repeats as part 
of a polyadenylated transcript. Using Southern blotting, 
we identified two lines: Sense-800 PolyA and Sense-1000 
PolyA, which harboured ~ 800 and ~ 1000 repeats, respec-
tively (Online Resource Fig. 8). In addition, we found 
lines carrying expansions larger than expected, consistent 
with de novo expansion events. We, therefore, selected 
one of these lines Sense-> 1000 PolyA (approximately 
2000–5000 repeats) for further characterisation (Online 
Resource Fig. 8).
When we expressed these constructs in adult neurons, 
we observed abundant nuclear and cytoplasmic RNA 
foci in up to 47% of cells (Fig. 2a, b). Unexpectedly we 
Fig. 1  Expression of C9orf72 sense RNA-only repeats is not strongly 
toxic to Drosophila neurons. a Diagram of the constructs gener-
ated. RO repeats were either cloned directly into the vector, forming 
part of a polyadenylated transcript (PolyA) or cloned into an intron 
within the eGFP coding sequence (Intronic). 5× Gal4 DNA binding 
domain (G4BD), heat-shock promoter (Prom), late SV40 termination 
and polyadenylation sequence (SV40/PolyA). b Fluorescence in  situ 
hybridisation was performed to assess foci formation (GGG GCC , 
red). Expression was induced in adult Drosophila neurons using the 
elavGS driver, leading to the formation of largely cytoplasmic RNA 
puncta in Sense-PolyA-1 flies, and intranuclear RNA foci in Sense-
Intronic-1 flies. Scale bar 2.5  μm. c Analysis of lifespan of Sense-
PolyA-1 and Sense-Intronic-1 flies fed RU486 to induce expression 
(+RU) or controls where expression was not induced (−RU). In both 
cases a significant lifespan extension was observed upon transgene 
expression (Sense-PolyA-1, median lifespan −RU  =  83.5  days 
+RU  =  89  days, P  =  6.91E−5, log rank test; Sense-Intronic-1, 
median lifespan −RU = 79 days +RU = 89 days, P = 9.76E−19, log 
rank test). d Negative geotaxis assays performed on Sense-PolyA-1 
and Sense-Intronic-1 flies expressing the transgene (+RU) and con-
trols (−RU). A slight reduction in climbing ability is observed in 
Sense-PolyA-1 flies (ordinal logistic regression, interaction of RU 
status and time P = 0.00025), whilst no significant effect is seen in 
Sense-Intronic-1 flies P = 0.47). Error bars are ± SEM. Genotypes: 
w; UAS-Sense-PolyA-1/+; elavGS/+ (Sense-PolyA-1), w; UAS-
Sense-Intronic-1/+; elavGS/+ (Sense-Intronic-1)
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observed a lower number of foci in Sense > 1000 PolyA 
flies compared to Sense-800 PolyA and Sense-1000 
PolyA flies. In addition to the driver control, we did not 
observe an appreciable number of foci (< 0.5% of nuclei) 
in flies carrying (but not expressing) the repeat transgene 
(Fig. 2b, Online Resource Fig. 3), indicating that signal is 
not caused by the probe interacting non-specifically with 
other cellular components, including genomic DNA.
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Fig. 2  Expression of ~  1000 RNA-only repeats or greater causes 
the production of large numbers of RNA foci but does not induce 
strong toxicity when expressed in adult Drosophila neurons. a Fluo-
rescence in  situ hybridisation against sense RNA foci reveals abun-
dant RNA foci are present in all lines expressing ~ 1000 RO repeats 
(Sense-800 PolyA and Sense-1000 PolyA) and Sense >  1000 RO 
repeats (Sense  >  1000 PolyA). Scale bar 2.5  μm. b Quantification 
of the % of foci containing nuclei (%foci+ nuclei) within each line. 
No foci+ nuclei are detected in driver alone (elavGS/+) and very few 
observed in transgene without the driver (Sense-800 PolyA/+) lines. 
A linear model was fitted to the data (effect of genotype P < 0.0001), 
and comparisons between groups made using orthogonal contrasts 
(all contrasts shown in Online Resource Table  1). A significantly 
higher proportion of nuclei were foci+ in ~  100 repeat  Sense-
Intronic flies vs. ~  100 repeat  PolyA flies (**P  =  0.0071). A sig-
nificantly higher proportion of foci+ nuclei were observed in 800 to 
> 1000 repeat-expressing flies compared to ~ 100 repeat-expressing 
flies (***P  <  0.0001). Fewer foci were observed in >  1000-repeat-
expressing flies vs. 800–1000 repeat (**P = 0.0039). 3–4 brains per 
genotype were examined. Bars are mean ± SEM. c Lifespans of flies 
expressing long sense constructs (+RU) vs. controls (−RU) using the 
elavGS driver. Significant lifespan extensions are observed in Sense-
800 PolyA (median lifespan −RU  =  83.5  days +RU  =  90.5  days, 
P  =  4.07E−10 log rank test) and Sense  >  1000 PolyA-express-
ing flies (median lifespan −RU  =  86.5  days +RU  =  90.5  days, 
P = 4.21E−06 log rank test). Lifespan of Sense-1000 PolyA-express-
ing flies was not significantly different (median lifespan −RU = 86.5, 
+RU = 86.5, P = 0.75, log rank test). d Negative geotaxis assays per-
formed on flies expressing the transgene (+RU) and controls (−RU) 
using the elavGS driver. In Sense-800 PolyA flies, a slight reduction 
in climbing ability is observed with age vs. controls (ordinal logis-
tic regression, interaction of RU status and time P = 0.0281); how-
ever, no significant differences were observed in Sense-1000 PolyA 
(P  =  0.328) or Sense  >  1000 PolyA (P  =  0.231)-expressing flies. 
Error bars are ±  SEM. Genotypes: w; +; elavGS/+ (elavGS/+), w; 
UAS-Sense-800 PolyA/+; +  (Sense-800 PolyA/+), w; UAS-Sense-
PolyA-1/+; elavGS/+  (Sense-PolyA-1), w; UAS-Sense-Intronic-1/+; 
elavGS/+ (Sense-Intronic-1), w; UAS-Sense-800 PolyA/+; elavGS/+ 
(Sense-800 PolyA), w; UAS-Sense-1000 PolyA/+; elavGS/+ 
(Sense-1000 PolyA), w; UAS-Sense  >  1000 PolyA/+; elavGS/+ 
(Sense > 1000 PolyA)
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Expression of > 1000 sense RNA‑only repeats does 
not cause typical neurodegenerative phenotypes
Despite the presence of abundant RNA foci, Sense-800 
PolyA, Sense-1000 PolyA and Sense > 1000 PolyA flies 
did not show a reduction in lifespan in females (Fig. 2c). We 
additionally assessed lifespan in male flies, and observed 
a significant but extremely modest reduction in lifespan 
with repeat expression (Online Resource Fig. 9). Whilst we 
observed a small decline in climbing ability of Sense-800 
PolyA flies at late ages this was not consistently replicated in 
either Sense-1000 PolyA flies or Sense > 1000 PolyA flies 
(Fig. 2d). We additionally failed to observe a rough eye phe-
notype or eclosion defect when constructs were expressed 
using the GMR-Gal4 driver (Online Resource Fig. 7).
To ensure that the lack of typical neurodegenerative phe-
notypes was not caused by repeat length instability, we per-
formed Southern blotting on the flies used in the lifespan 
and negative geotaxis assays, and observed conservation of 
repeat length (Online Resource Fig. 8b).
Antisense polyA RNA repeats accumulate 
in the cytoplasm and intronic antisense RNA repeats 
accumulate in the nucleus
The potential role of antisense C9orf72 repeat RNA in 
neurodegeneration has thus far not been investigated in 
Drosophila. Because the stop codons present in the RO 
constructs are also able to block translation in the antisense 
direction, we created flies capable of expressing ~ 100 anti-
sense RO repeats by reversing the orientation of the repeat 
construct. We reasoned that intronic localisation would 
enhance nuclear antisense RNA foci formation as found for 
sense repeats; therefore, we created two sets of constructs, 
polyadenylated and intronic. We derived multiple independ-
ent transgenic lines and screened for repeat expansions of 
the correct size using Southern blotting (Online Resource 
Fig. 10), deriving two lines capable of expressing ~ 100 RO 
sense repeats either as part of a processed polyadenylated 
RNA transcript (AS-PolyA-1 and AS-PolyA-2) or from an 
intron (AS-Intronic-1 and AS-Intronic-2). eGFP expression 
was confirmed in intronic flies demonstrating correct splic-
ing (Online Resource Fig. 2). Due to repeat instability, we 
were unable to create DNA constructs of > 108 antisense 
RO repeats.
We assessed antisense RNA foci formation in adult Dros-
ophila neurons using FISH. As in the sense flies, in antisense 
polyA expressing flies, we observed frequent cytoplasmic 
RNA signals in adult neurons, with occasional intranuclear 
puncta (2–3% of cells, Fig. 3a). As anticipated, in antisense 
intronic RO repeat-expressing flies we observed a shift 
in RNA localisation to predominantly nuclear RNA foci, 
with foci present in approximately 8–11% of cells (Fig. 3b). 
Therefore, these novel lines allow investigation of both cyto-
plasmic and nuclear antisense C9orf72 repeat RNA toxicity.
Expression of antisense RNA‑only C9orf72 repeats 
does not cause typical neurodegenerative 
phenotypes
Flies expressing antisense polyA or intronic RO repeats 
did not show a reduced lifespan (Fig. 3c, Online resource 
Fig. 4b, d) or consistent effects on climbing ability (Fig. 3d, 
Online Resource Fig. 6b, d). In addition, no rough eye phe-
notype or eclosion defect was observed when antisense con-
structs were expressed during development using the GMR-
Gal4 driver (Online Resources Fig. 7).
RNA‑only repeat RNA foci sequester RNA‑binding 
proteins
Sequestration of RNA-binding proteins is thought to be a 
critical mediator of RNA toxicity [55]. To verify that the 
RNA foci formed by RO repeats sequester RNA-binding 
proteins we performed FISH coupled with immunofluores-
cence to determine whether the foci present in Sense-800 
PolyA-expressing flies could sequester Glorund (Glo), the 
Drosophila ortholog of hnRNP H, which has been identified 
in multiple independent studies as a C9orf72 sense RNA foci 
interacting protein [12, 13, 25, 32]. We found puncta of Glo 
colocalised with an average of 15% of foci (Fig. 4), showing 
that foci formed by RO repeats are capable of sequestering 
endogenous Drosophila proteins. Therefore, RO repeat RNA 
foci recapitulate this key property of RNA foci observed in 
patient material, without causing overt toxicity.
To examine whether loss of function of Glo alone is suf-
ficient to induce a neurodegenerative phenotype, we knocked 
down Glo in developing photoreceptor neurons using GMR-
Gal4. We observed a significant knockdown when express-
ing Glo RNAi at 29 °C (Online Resource Fig. 11a), we failed 
to observe either a rough eye phenotype, or eclosion defect 
compared to controls (Online Resource Fig. 11b–e). This 
suggests that even if the RNA foci were sequestering large 
amounts of Glo, this would be unlikely to translate into a 
toxic phenotype.
Production of dipeptide proteins is suppressed 
from RNA‑only repeats
To quantitatively assess whether production of DPRs is pre-
vented in our models, we developed in-house Meso Scale 
Discovery (MSD) immunoassays, using antibodies specific 
for poly-GP or poly-GR [57] (Online Resource Fig. 12).
We first assessed all fly lines, sense and antisense, for 
expression of poly-GP, the only DPR to be produced from 
RAN translation of both sense and antisense RNA. We have 
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previously observed robust expression of poly-GP in flies 
expressing 36 GGG GCC repeats (36R) using western blot-
ting [37], and, as expected, we observed a large poly-GP 
signal in these flies compared to uninduced controls by 
MSD immunoassay (Fig. 5a). We additionally observed a 
low-level production of poly-GP, greater than in controls, 
in some of the sense- and antisense repeat-expressing lines, 
despite the presence of stop codons. This is potentially due 
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Fig. 3  Antisense RNA forms foci, but does not induce strong toxicity 
when expressed in Drosophila neurons. a Fluorescence in situ hybridi-
sation was performed to assess antisense foci formation (GGC CCC 
, green). Expression was induced in adult Drosophila neurons using the 
elavGS driver, leading to largely cytoplasmic RNA signal in AS-PolyA-1 
flies, and predominantly intranuclear RNA foci in AS-Intronic-1 flies. 
Scale bar 2.5  μm. b Quantification of the % of foci containing nuclei 
(%foci+ nuclei) within each line. No foci+ nuclei are detected in driver 
alone (elavGS/+) and very few observed in transgene alone (Sense-
800 PolyA-1/+) lines. A linear model was fitted to the data (effect of 
genotype P  <  0.0001), and comparisons between groups made using 
orthogonal contrasts (all contrasts shown in Online Resource Table 2). 
A significantly higher proportion of nuclei were foci+ in AS-Intronic 
flies vs. AS-PolyA flies (***P < 0.0001). 2–4 brains per genotype were 
examined. Bars are mean ± SEM. c Lifespans of flies expressing anti-
sense constructs (+RU) vs. controls (−RU) using the elavGS driver. A 
significant extension of lifespan is observed in AS-PolyA-1 (median 
lifespan −RU = 89 days +RU = 93.5 days, P = 5.20E−8 log rank test) or 
AS-Intronic-1 flies (median lifespan −RU = 75.0 days +RU = 82.5 days, 
P  =  4.92E−8 log rank test). d Negative geotaxis assays performed on 
AS-PolyA-1 and AS-Intronic-1 flies expressing the transgene (+RU) 
and controls (−RU) using the elavGS driver. In AS-PolyA-1 flies, no sig-
nificant difference in climbing ability is observed with age vs. controls 
(ordinal logistic regression, interaction of RU status and time P = 0.988), 
or AS-Intronic-1-expressing flies (P  =  0.439). Error bars are  ±  SEM. 
Genotypes: w; +; elavGS/+ (elavGS/+), w; UAS-Sense-800 PolyA/+; 
+ (Sense-800 PolyA/+), UAS-AS-polyA-1/+; elavGS/+ (AS-PolyA-1), 
UAS-AS-Intronic-1/+; elavGS/+ (AS-Intronic-1)
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to a limited amount of RAN translation occurring between 
the stop codons of the interrupted repeats. Interestingly, a 
stronger signal was observed in Sense-PolyA-1 flies com-
pared to controls than in intronic or 1000 repeat-expressing 
lines. Sense-PolyA-1 flies probably express higher levels 
of poly-GP because the relatively short repeat length and 
nuclear export to the cytoplasm favour RAN translation in 
this line. Crucially, when we assessed the levels of the toxic 
DPR poly-GR, in sense RO repeat expressing lines that dis-
played a significant poly-GP signal, we failed to observe any 
poly-GR above background (Fig. 5b), whereas poly-GR was 
present in the brains of 36R expressing positive controls, as 
expected. This lack of poly-GR is consistent with the lack 
of toxicity observed in these lines.
Discussion
Here, we have demonstrated that expression in adult neurons 
of both sense and antisense C9orf72 mutation-associated 
repeat RNA does not produce typical neurodegeneration-
associated phenotypes in Drosophila, despite the formation 
of sense and antisense cytoplasmic RNA, or nuclear RNA 
foci.
We, and others, have previously demonstrated that over-
expression of C9orf72 repeat RNA is extremely toxic to 
Drosophila neurons, resulting in a dramatically reduced 
lifespan [19, 37, 56]. However, the introduction of regularly 
interspersed stop codons, and the resulting reduced produc-
tion of DPRs, prevents this toxicity, suggesting that it is 
dependent on DPR production in these flies [37], a finding 
further supported by our current study.
We have here demonstrated that the genomic context of 
repeat RNA (intronic vs. polyA) affects intranuclear RNA 
foci formation, presumably because splicing of the intronic 
repeats prevents the nuclear export of repeat RNA. This is in 
line with previous studies that have confirmed that intronic 
localisation of repeat RNA favours its nuclear retention and 
nuclear RNA foci formation [53, 54]. It has additionally 
been demonstrated that reduced nuclear export of repeat 
RNA via knockdown of SRSF1 enhances nuclear RNA foci 
formation in patient iPSC-derived astrocytes [24]. We have 
additionally observed enhanced foci formation with increas-
ing repeat length, consistent with our previous observations 
in transfected cells [37]. It is interesting to note that although 
we unexpectedly detected RAN translated poly-GP in some 
of our stop codon-interrupted repeat lines, the highest lev-
els of poly-GP protein were observed in Sense-PolyA-1 
flies expressing ~ 100 repeats. In these flies repeat RNA 
was largely cytoplasmic, compared with intronic or 800 to 
> 1000 repeat expressing lines where RNA was predomi-
nantly accumulated in the nucleus. Interventions that affect 
nucleocytoplasmic transport have previously been demon-
strated as modifiers of toxicity in C9orf72 models [6, 19, 
27, 58]. Interestingly, it has been shown that knockdown 
or chemical inhibition of the Drosophila ortholog of XPO1 
(emb) significantly rescues toxicity in repeat-expressing 
flies, but enhances toxicity in recodonised DPR-expressing 
flies implicating XPO1 in the nuclear export of repeat GGG 
GCC RNA, and suggesting that preventing nuclear export of 
repeat RNA may be of therapeutic value [58].
The role of repeat RNA in the pathogenesis of C9orf72 
mutation-associated ALS/FTD is currently contentious. 
C9orf72 repeat RNA forms secondary structures such as 
hairpins and G-quadruplexes, leading to the formation of 
intranuclear RNA foci, which are generally assumed to 
become toxic by the sequestration of RNA-binding pro-
teins [23]. One study has found a correlation between the 
presence of antisense RNA foci and nuclear clearance of 
TDP-43 [13]; however, other studies have demonstrated 
that neither sense nor antisense nuclear RNA foci burden 
consistently correlate well with the region-specific neuro-
degeneration observed in patient post-mortem tissue [15, 
38]. Additionally, despite the formation of large numbers of 
nuclear RNA foci in recent bacterial artificial chromosome 
(BAC) mouse models, toxicity is only observed in some of 
the mice [26, 34, 42, 44]. In one BAC mouse model regional 
Fig. 4  Glorund colocalises with sense RNA foci in adult Drosophila 
neurons. Fluorescence in situ hybridisation against sense foci (GGG 
GCC , red) was coupled with immunofluorescence against glorund 
(green). Bright puncta of glorund staining were found to colocal-
ise with sense RNA foci (examples of colocalising puncta shown 
by white arrowheads). An average of 14.8% of sense RNA foci was 
found to colocalise with glorund puncta (±  4.26% SEM, based on 
167 foci scored across 3 separate brains). Scale bar 5 μm. Genotype: 
w; UAS-Sense-800 PolyA/+; elavGS/+
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neurodegenerative phenotypes were positively correlated 
with the presence of antisense RNA foci. However, the same 
study found that TDP-43 pathology and neurodegeneration 
could be observed independent of the formation of nuclear 
RNA foci in mice expressing short repeat lengths [34].
It is possible that hexanucleotide RNA is toxic through 
mechanisms independent of intranuclear RNA foci for-
mation. Recently, it was demonstrated that toxicity corre-
lates with the presence of neuritic RNA foci in sense RNA 
expressing primary neurons [9]. Our current models provide 
evidence that in Drosophila neither cytoplasmic nor nuclear 
RNA are sufficient to induce a strong pathological pheno-
type. This is consistent with the results of a previous study 
examining intronic sense foci in Drosophila, which also did 
not observe a neurodegenerative phenotype [53].
Previous studies have observed toxicity in Drosophila 
expressing (GGG GCC )15–CTC GAG –(GGG GCC )15 repeats 
[56, 58] or (GGG GCC )48-58 repeats [9, 19]. However, it is 
not clear whether toxicity is primarily driven through the 
presence of repeat RNA or DPRs. Here we have used newly 
described sensitive ELISA assays to assess accurately the 
level of poly-GP and poly-GR in our Drosophila mod-
els, without having to employ the strong overexpression 
paradigm necessary to detect DPRs by immunoblot [37, 58]. 
We note with interest, that in our model system soluble poly-
GP was present at approximately 10 times the abundance of 
poly-GR, potentially due to a high rate of turnover of poly-
GR [30], or the influence of as-yet-unknown cis factors in 
the RNA sequence. The lack of toxicity we observed in our 
RNA-only models is correlated with a lack of expression of 
poly-GR, consistent with its role in mediating the neurotoxic 
phenotypes seen in Drosophila. Notably, the only consistent 
toxic phenotype we observed in any genotype was a modest 
reduction in climbing ability in ~ 100 repeat Sense-PolyA 
flies as well as a slight rough-eye phenotype when these flies 
were crossed to GMR-Gal4. These flies showed the largest 
production of poly-GP protein, suggesting that DPRs present 
at low levels, or below the level of detection may still be 
capable of inducing mildly toxic phenotypes.
It is possible that proteins that bind to hexanucleotide 
RNA in humans are not well conserved in Drosophila, 
rendering flies resistant to RNA toxicity. Some identified 
sense RNA-binding proteins like Zfp106 do not have highly 
homologous orthologs in Drosophila [11]. However, gen-
erally RNA-binding proteins are well conserved between 
Drosophila and humans [21]. We observe sequestration of 
Fig. 5  RANT is suppressed in RNA-only flies. a Assessment of 
poly-GP expression. Heads of flies induced on RU486 for 7  days 
(+RU) and controls (−RU) were lysed and dipeptide protein con-
centration measured by immunoassay. Poly-GP is detectable in 
significantly higher abundance in 36R-expressing flies compared 
to non-induced controls (***P  =  0.0002, two-tailed t test, +RU 
n = 2, −RU n = 3). Additionally a significantly higher level of poly-
GP was observed in lines Sense-PolyA-1 (****P  <  0.0001, two-
tailed t test, +RU n = 4, −RU n = 4), AS-PolyA-1 (**P = 0.0017, 
Welch’s two-tailed t test, +RU n = 4, −RU n = 3), Sense-Intronic-1 
(****P < 0.0001, two-tailed t test, both conditions n = 3), and Sense-
800 PolyA (**P = 0.0036, two-tailed t test, both conditions n = 3). 
No differences in poly-GP levels were observed in lines express-
ing AS-Intronic-1, Sense-1000 PolyA and Sense  >  1000 PolyA vs. 
controls (Sense > 1000 PolyA and AS-Intronic-1 +RU n = 4, n = 3 
for other conditions). b Assessment of poly-GR expression. Poly-
GR expression was assessed by immunoassay. Poly-GR was signifi-
cantly higher in 36R-expressing flies vs. −RU control (**P = 0.0019, 
Welch’s two-tailed t test, +RU n  =  4, −RU n  =  3). No significant 
difference in poly-GR was observed in Sense-PolyA-1 (P = 0.4006, 
Welch’s two-tailed t test, +RU n = 4, −RU n = 3), Sense-Intronic-1 
(P  =  0.4226, Welch’s two-tailed t test, both conditions n  =  3) or 
Sense-800 PolyA (P = 0.4226, Welch’s two-tailed t test, +RU n = 4, 
−RU n = 3). Bars are Mean ± SEM, individual replicates are shown 
as circles. Genotypes: w; UAS-Sense-PolyA-1/+; elavGS/+ (Sense-
PolyA-1), w; UAS-Sense-Intronic-1/+; elavGS/+  (Sense-Intronic-1), 
w; UAS-Sense-800 PolyA/+; elavGS/+ (Sense-800 PolyA), w; 
UAS-Sense-1000 PolyA/+; elavGS/+ (Sense-1000 PolyA), w; UAS-
Sense > 1000 PolyA/+; elavGS/+ (Sense > 1000 PolyA), w; UAS-
AS-PolyA-1/+; elavGS/+ (AS-PolyA-1), w; UAS-AS-Intronic-1/+; 
elavGS/+ (AS-Intronic-1), w; UAS-36R/+; elavGS/+ (36R)
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Glo, the Drosophila ortholog of hnRNP H, a commonly 
identified hexanucleotide RNA-interacting protein [12, 14, 
22, 25, 32], suggesting that repeat RNA sequesters RNA-
binding proteins in vivo in Drosophila. We have confirmed 
that Glo knockdown driven by RNAi is insufficient to induce 
rough-eye and eclosion phenotypes, consistent with a previ-
ous report which demonstrated a lack of eye phenotype and 
only a very slight defect in climbing ability when Glo knock-
down is driven throughout development using the constitu-
tively active elav-Gal4 driver [1]. These results, therefore, 
imply that although repeat RNA is capable of sequestering 
Drosophila RNA-binding proteins per se, that the particu-
lar RNA-binding proteins that are sequestered do not pro-
duce overt phenotypes associated with neurodegeneration 
in Drosophila.
Although we did not observe a typical neurodegenerative 
phenotype, a lifespan extension was observed in females in 
almost all repeat RNA expressing lines, and does not occur 
in controls. This lifespan extension does not correlate with 
the production of DPRs, suggesting that it is dependent on 
sense and antisense RNA. The mechanism causing this effect 
is currently unknown, but both sense and antisense C9orf72-
associated hexanucleotide hairpins have been demonstrated 
to bind a large number of proteins with a similar degree 
of avidity in vitro, making a shared mechanism of action 
possible [22]. Additionally, it has previously been noted 
that repeat expansion disease-associated hairpin RNAs can 
induce similar transcriptional changes in Drosophila neurons 
despite having differing primary sequences [18]. Intrigu-
ingly, expression of hairpin RNA has been shown to disrupt 
the Akt/GSK3-β signalling pathway [18], the disruption of 
which we have previously identified as having pro-longevity 
effects in Drosophila [10]. Further work will be required to 
fully elucidate the mechanism(s) by which this occurs, but it 
does indicate some biological effect of sense and antisense 
repeat RNA, albeit not sufficient to cause overt toxicity.
A full understanding of the mechanisms by which the 
C9orf72 repeat expansion leads to toxicity are essential 
in designing effective therapeutic interventions. Several 
groups have focused their efforts on antisense oligonucleo-
tides (ASOs) targeting the sense RNA stand [17, 31, 47], or 
G-quadruplex binding molecules, which target the sense-
strand-specific G-quadruplex RNA secondary structure [48, 
57, 58]. These approaches prevent the formation of sense 
RNA foci and the production of the more highly abundant 
sense dipeptide proteins. However, if antisense RNA induces 
toxicity in patients, these interventions may be of limited 
clinical effectiveness. Our results suggest that sense and anti-
sense RNA are well tolerated in Drosophila, suggesting that 
therapeutic interventions that act to reduce dipeptide repeat 
protein production will be of importance as a therapeutic 
endpoint.
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